Launch Blue Ventures is a venture capital management services program supporting development, provision and management of venture capital to benefit Kentucky startups.
The annual event offers attendees an opportunity to learn about the innovative work of faculty, alumni and community startups. Keynote speakers Elaine and Myron Jacobson will receive the Lee T. Todd Lifetime Achievement Award for Entrepreneurship. The co-founders of Niadyne Pharma have worked as a research team for nearly 50 years.
The STEM Through Authentic Research and Training (START) program at UK is creating a unique pipeline to promote careers for underrepresented populations, first-generation college students, and girls and women in STEM. START is funded by a five-year, $1.3 million Science Education Partnership Award (SEPA) from the National Institute of General Medical Sciences.
As part of the partnership, Summit will manufacture a multidose nasal spray presentation of AdCOVID, Altimmune’s intranasal COVID-19 vaccine candidate. AdCOVID is currently being evaluated in a phase 1 clinical trial of healthy adult volunteers between the ages of 18 and 55.
The University of Kentucky and Lexmark International are embarking on the next chapter in their longstanding partnership through a new agreement designed to accelerate innovation and spur economic growth.
While equestrian helmets protect riders, there is no test in place to evaluate a helmet’s crush resistance. UK students are working to develop a helmet testing method and collect data that will hopefully serve as the start of a crushing-safety standard for helmets.
The new facility will be named “The Core — Collaboration. Research. Entrepreneurship,” and is designed to be the first stop for companies looking to locate on the research campus.
UK's Office of Technology Commercialization (OTC), on behalf of UK Research Foundation (UKRF), was awarded a three-year $600,000 grant from the Economic Development Administration (EDA) Build to Scale Program, one of 52 projects funded from 36 states.
